Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity (Q74485767)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Belinda Pinto Simoes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Aglair B Garcia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Maria G Marques

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Benedito A Fonseca

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Miriam L Rodrigues

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Norma T Foss

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

803-807

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

Blastic NK-cell lymphoma expressing terminal deoxynucleotidyl transferase with Homer-Wright type pseudorosettes formation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

Cutaneous monomorphous CD4- and CD56-positive large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

Malignant T gamma/delta lymphoproliferative disease with natural killer lytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

Aggressive variant of morphologically typical T large granular lymphocyte leukemia/lymphoma lacking NK cell markers

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

Selective Expansion and Partial Activation of Human NK Cells and NK Receptor-Positive T Cells by IL-2 and IL-15

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900014-0

7 January 2021

10.1016/S0145-2126(02)00014-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12127554%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference